Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeaki Suzuki

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2020
Encephalitis as an immune-related adverse eventShigeaki Suzuki
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Significance of Antistriational Antibodies for Immune Checkpoint Inhibitor-Related Myositis: Comment on the Article by Aldrich et alShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 11, 2018
[Immune Checkpoint Inhibitors and Neuromuscular Adverse Events]Shigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 10, 2013
[Non-motor symptoms in myasthenia gravis: attributed to T-cell clones from thymoma]Shigeaki Suzuki
Immunological Medicine|February 27, 2025
Pathogenesis and detection methods of anti-acetylcholine receptor antibodies in myasthenia gravisShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 14, 2024
[Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events]Shigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 8, 2024
[Clinical Features of Myasthenia Gravis as an Immune-related Adverse Event]Shigeaki Suzuki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Myasthenia Gravis and Myositis(PD-1 Myopathy)]Shigeaki Suzuki
The Lancet. Neurology|June 19, 2021
Targeted molecular therapy for myasthenia gravisShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 13, 2011
[Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance]Shigeaki Suzuki
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2020
Encephalitis as an immune-related adverse eventShigeaki Suzuki
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2021
Significance of Antistriational Antibodies for Immune Checkpoint Inhibitor-Related Myositis: Comment on the Article by Aldrich et alShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 11, 2018
[Immune Checkpoint Inhibitors and Neuromuscular Adverse Events]Shigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 10, 2013
[Non-motor symptoms in myasthenia gravis: attributed to T-cell clones from thymoma]Shigeaki Suzuki
Immunological Medicine|February 27, 2025
Pathogenesis and detection methods of anti-acetylcholine receptor antibodies in myasthenia gravisShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 14, 2024
[Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events]Shigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 8, 2024
[Clinical Features of Myasthenia Gravis as an Immune-related Adverse Event]Shigeaki Suzuki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Myasthenia Gravis and Myositis(PD-1 Myopathy)]Shigeaki Suzuki
The Lancet. Neurology|June 19, 2021
Targeted molecular therapy for myasthenia gravisShigeaki Suzuki
Brain and Nerve = Shinkei Kenkyu No Shinpo|July 13, 2011
[Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance]Shigeaki Suzuki
Pageof 19